March 22, 2011 - Terumo Cardiovascular Systems (CVS) said it agreed to the terms of a consent decree with the U.S. Food and Drug Administration (FDA) regarding quality system improvements at the company's Ann Arbor, Mich., facility. The agreement will be subject to the approval of the United States District Court for the Eastern District of Michigan.
